OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: MindImmune Therapeutics, Inc.

1 Projects | 1 Researchers | $1,835,000 Invested

2021

MindImmune Therapeutics, Inc.

Frank Menniti, PhD

Measurement of immune cell recruitment as a biomarker of neuroinflammation in Alzheimer's disease and other diseases of the central nervous system

  • Funding Amount: $1,835,000
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Target: Neuroinflammation
  • Status: Active